Original Query: ALL
Previous Study | Return to List | Next Study

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer (SPRAY III)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01361607
Recruitment Status : Completed
First Posted : May 27, 2011
Last Update Posted : July 6, 2016
Otsuka Pharmaceutical Development & Commercialization, Inc.
Information provided by (Responsible Party):
GW Pharmaceuticals Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2014
  Study Completion Date : November 2014
  Certification/Extension First Submitted : June 24, 2016